Retinoid receptors in human breast carcinoma: Possible modulators of in situ estrogen metabolism

Breast Cancer Research and Treatment

Volumn 65, Issue 1, 2001, Pages 31-40

  Suzuki, T ^a   Moriya, T ^b   Sugawara, A ^a   Ariga, N ^b   Takabayashi, H ^a   Sasano, H ^b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Breast carcinoma; Estrogen; Immunohistochemistry; RAR; Retinoids; RXR

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN METABOLISM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; METABOLIC REGULATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; ESTROGENS; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; TRANSCRIPTION FACTORS;

EID: 0035113162     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006433929792     Document Type: Article

References (47)

1. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids)
2. Can dietary β-carotine materially reduce human cancer rates?
3. Retinoids as preventive and therapeutic anticancer agents (Part 1)
4. A human retinoic acid receptor which belongs to the family of nuclear receptors
5. Identification of a receptor for the morphogen retinoic acid
6. A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma
7. Identification of a second human retinoic acid receptor
8. A third human retinoic acid receptor hRARγ
9. HH-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen responsive element
10. Nuclear receptor that identifies a novel retinoic acid response pathway
11. Characterization of three RXR genes that mediate the action of 9-cis-retinoic acid
12. Multiplicity generates diversity in the retinoic acid signalling pathways
13. A decade of molecular biology of retinoic acid receptors
14. Effect of retinoic acid and 4-hydroxytamoxifen on human breast cancer cell lines
15. Retinoic acid inhibition of human breast carcinoma proliferation is accompanied by inhibition of the synthesis of a M 39,000 protein
16. Retinoic acid resistance of estradiol-independent breast cancer cell lines coincidence with diminished expression of functional retinoic acid receptors
17. Estradiol induction of retinoic acid receptors in human breast cancer cells
18. Immunohistochemical analysis of retinoic acid receptor-α in human breast tumors
19. Loss of retinoic acid receptor b expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer
20. Progressive decrease in nuclear retinoic acid receptor β messenger RNA level during breast carcinogenesis
21. Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years
22. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer. Experience from a large study with long-term follow-up
23. Isoform-specific retinoid-X receptor (RXR) antibodies detect differential expression of RXR proteins in the pituitary gland
24. Immunohistochemical expression of retinoid X receptor isoforms in human pituitaries and pituitary adenomas
25. Immunohistochemical analysis of 17β-hydroxysteroid dehydrogenase in benign and malignant human breast tissue
26. Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: Relationship to expression of steroidogenic enzymes
27. Cyclic changes of vasculature and vascular phenotypes in normal human ovaries
28. 17β-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: A correlation to clinicopathological parameters
29. Immunohistochemical localization of Ad4-binding protein with correlation to steroidogenic enzyme expression in cycling human ovaries and sex cord stromal tumors
30. Protein measurements with the Folin phenol reagent
31. The mouse Rxrb gene encoding RXRβ: Genomic organization and two mRNA isoforms generated by alternative splicing of transcripts initiated from CpG island promoters
32. A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor
33. Retinoic acid receptors and retinoid binding proteins in endometrial adenocarcinoma: Differential expression of cellular retinoid binding proteins in endometrioid tumours
34. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer
35. Cellular distribution of retinoic acid receptor-alpha protein in serous adenocarcinomas of ovarian, tubal, and peritoneal origin: Comparison with estrogen receptor status
36. Retinoid resistant estrogen receptor negative human breast carcinoma cells transfected with retinoic acid receptor α acquire sensitivity to growth inhibition by retinoids
37. Retinoic acid receptor α expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status
38. Expression and regulation of retinoic acid receptors in human breast cancer cells
39. Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA
40. Characterization of cDNAs for human estradiol 17β-dehydrogenase and assignment of the gene to chromosome 17: Evidence of two mRNA species with distinct 5′-termini in human placenta
41. Isolation and sequencing of a cDNA clone encoding human placental 17β-estradiol dehydrogenase: Identification of the putative cofactor binding site
42. Expression cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteroid dehydrogenase activity
43. Aromatase and 17β-hydroxysteroid dehydrogenase type 1 in human breast carcinoma
44. Regulation of estradiol 17β-hydroxysteroid dehydrogenase expression and activity by retinoic acid in T47D breast cancer cells
45. Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF- 7 human breast cancer cells
46. Proliferation index as a prognostic marker in breast cancer
47. Phase II trial of 13-cis-retinoic acid in metastatic breast cancer